Lisata Therapeutics, Inc.LSTANASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank57
3Y CAGR-9.7%
5Y CAGR+38.0%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
-9.7%/yr
vs +2.3%/yr prior
5Y CAGR
+38.0%/yr
Recent deceleration
Acceleration
-12.0pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
5x
Strong expansion
Streak
2 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$660000.00-59.4%
2024$1.63M-35.9%
2023$2.54M+182.9%
2022$897000.00+1080.3%
2021$76000.00-42.4%
2020$132000.00-82.2%
2019$740000.00-9.6%
2018$819000.00+880.0%
2017$-105000.00+94.0%
2016$-1.76M-